SIRT1 and ovarian carcinoma: Miyamoto et al. found higher expression of SIRT1 in endometrioid, mucinous, and clear cell carcinomas compared to normal ovarian tissues and follicles, suggesting that high expression of SIRT1 is associated with cisplatin resistance in ovarian cancer cells and is one of the main reasons for poor prognosis in ovarian cancer patients [65].